# FDA Inspection 883465 - Aspirus Riverview Hospital and Clinics - June 20, 2014

Source: https://www.keypedia.com/records/fda_inspections/aspirus-riverview-hospital-and-clinics/5d8c4b29-1aa0-41c2-9da0-da9ef6b653e4
Source feed: FDA_Inspections

> FDA Inspection 883465 for Aspirus Riverview Hospital and Clinics on June 20, 2014. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 883465
- Company Name: Aspirus Riverview Hospital and Clinics
- Inspection Date: 2014-06-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 961415 - 2016-01-14](https://www.keypedia.com/records/fda_inspections/aspirus-riverview-hospital-and-clinics/e362e147-a573-41cb-8f06-01274276d96c)
- [FDA Inspection 779608 - 2012-04-27](https://www.keypedia.com/records/fda_inspections/aspirus-riverview-hospital-and-clinics/d8f4535c-be47-4be9-8738-fc6f1c869788)
- [FDA Inspection 629334 - 2009-11-05](https://www.keypedia.com/records/fda_inspections/aspirus-riverview-hospital-and-clinics/d00b6f40-9e4a-4a2a-9f5f-9a61e166e3ee)

Company: https://www.keypedia.com/companies/aspirus-riverview-hospital-and-clinics/80c84967-63f9-4531-aba3-6bb012929e20

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d